Delivery Order SPE2DB22D3009-SPE2DB25FBE32
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $2,832.92. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,684.93 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPin 2-pack auto-injectors (0.5mg/0.1ml) with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The GVOKE HypoPin is a glucagon emergency injection system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.51 to AmerisourceBergen Drug Corp for Gvoke HypoPen auto-injectors (1 mg/0.2 mL, 2-pack). This competitive award, issued on July 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of GVOKE HypopenPen auto-injectors (2-pack, 1 mg/0.2 ml formulation) with a ceiling value of $1,456.72. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and performance will be executed from the company's location in Conshohocken, Pennsylvania. The order is set for ultimate completion by August 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $3,234.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gvoke HypoPin 1-pack 1 mg/0.2 mL auto-injectors. This non-set-aside award will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. The delivery order represents a single transaction under AmerisourceBergen's broader contracting relationship with DLA for pharmaceutical and...
- The Defense Logistics Agency awarded a delivery order valued at $9,523.55 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBE32Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,028.47 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoPen 2-pack auto-injectors (0.5mg/0.1ml) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-competitive delivery order represents a firm fixed price transaction and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The product is a glucagon emergency injection device used for treating severe hypoglycemia in patients with diabetes, a critical pharmaceutical supply for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a prime vendor for the Defense Health Agency and other federal healthcare systems, supplying a comprehensive portfolio of medications, vaccines, and medical devices across multiple therapeutic areas. The parent contract provides a flexible procurement vehicle enabling the company to fulfill urgent medical supply needs for military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/29/25 |